Cargando…

Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2− advanced breast cancer

BACKGROUND: The phase III MONALEESA-7 trial (NCT02278120) assessed ribociclib + endocrine therapy (ET) versus ET in premenopausal women with HR+/HER2− advanced breast cancer (ABC). The relationship between work productivity loss (WPL) and domains of European Organisation for Research and Treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tripathy, Debu, Curteis, Tristan, Hurvitz, Sara, Yardley, Denise, Franke, Fabio, Babu, K. Govind, Wheatley-Price, Paul, Im, Young-Hyuck, Pencheva, Radost, Eddowes, Lucy A., Dionne, Pierre-Alexandre, Chandiwana, David, Pathak, Purnima, Lanoue, Brad, Harbeck, Nadia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891884/ https://www.ncbi.nlm.nih.gov/pubmed/35251320 http://dx.doi.org/10.1177/17588359221081203

Ejemplares similares

Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7)
por: Harbeck, Nadia, et al.
Publicado: (2020)

Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13
por: Coon, Cheryl D., et al.
Publicado: (2022)

Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR(+)/HER2(−) Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
por: Lu, Yen-Shen, et al.
Publicado: (2022)

Psychometric properties of the EORTC QLQ-C30 in Uganda
por: Naamala, Allen, et al.
Publicado: (2021)

Assessing measurement invariance in the EORTC QLQ-C30
por: van Roij, Janneke, et al.
Publicado: (2021)

A Multinational Pilot Study on Patients’ Perceptions of Advanced Neuroendocrine Neoplasms on the EORTC QLQ-C30 and EORTC QLQ-GINET21 Questionnaires
por: van Leeuwaarde, Rachel S., et al.
Publicado: (2022)

Reliability and Validity of the Arabic Version of the EORTC QLQ-C30 and QLQ-BR23 Questionnaires
por: Jassim, Ghufran, et al.
Publicado: (2020)

Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran
por: Khoshnevisan, Alireza, et al.
Publicado: (2012)

Comparing higher order models for the EORTC QLQ-C30
por: Gundy, Chad M., et al.
Publicado: (2011)

Health-related Quality of Life in Croatian General Population and Multiple Myeloma Patients Assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 Questionnaires
por: Ficko, Sanja Ledinski, et al.
Publicado: (2019)

Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma
por: Proskorovsky, Irina, et al.
Publicado: (2014)

Associations between the spiritual well-being (EORTC QLQ-SWB32) and quality of life (EORTC QLQ-C30) of patients receiving palliative care for cancer in Cyprus
por: Kyranou, Maria, et al.
Publicado: (2021)

Translation and Validation of the Sinhala Version of the EORTC-QLQ-CR29 Questionnaire
por: Wickramasinghe, Dakshitha P, et al.
Publicado: (2020)

Ribociclib plus fulvestrant for advanced breast cancer: Health-related quality-of-life analyses from the MONALEESA-3 study
por: Fasching, Peter A., et al.
Publicado: (2020)

Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer
por: Uwer, Lionel, et al.
Publicado: (2011)

Quality of life of patients after retropubic prostatectomy - Pre- and postoperative scores of the EORTC QLQ-C30 and QLQ-PR25
por: Bach, Peter, et al.
Publicado: (2011)

Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore
por: Tan, May Leng, et al.
Publicado: (2014)

Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer
por: Lin, Jin-Bo, et al.
Publicado: (2017)

Normative data for the EORTC QLQ-C30 from the Austrian general population
por: Lehmann, Jens, et al.
Publicado: (2020)

Korean Translation and Psychometric Evaluation of Korean Version EORTC QLQ-BRECON23
por: Bok, Soo-Kyung, et al.
Publicado: (2020)

Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after
por: Miret, Carme, et al.
Publicado: (2023)

Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21
por: Friend, E, et al.
Publicado: (2011)

International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26
por: Sztankay, Monika, et al.
Publicado: (2018)

Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials
por: Gamper, Eva M., et al.
Publicado: (2021)

Translation and adaptation of the EORTC QLQ-LC 29 for use in Chinese patients with lung cancer
por: Dai, Wei, et al.
Publicado: (2021)

Translation and validation of the EORTC QLQ-BR45 among Ethiopian breast cancer patients
por: Getu, Mikiyas Amare, et al.
Publicado: (2022)

Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26
por: Holzner, Bernhard, et al.
Publicado: (2012)

Genomic Profiling of Premenopausal HR+ and HER2– Metastatic Breast Cancer by Circulating Tumor DNA and Association of Genetic Alterations With Therapeutic Response to Endocrine Therapy and Ribociclib
por: Bardia, Aditya, et al.
Publicado: (2021)

Psychosocial Burden and Quality of Life of Lung Cancer Patients: Results of the EORTC QLQ-C30/QLQ-LC29 Questionnaire and Hornheide Screening Instrument
por: Koch, Myriam, et al.
Publicado: (2021)

The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30
por: McTaggart-Cowan, Helen, et al.
Publicado: (2019)

German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30
por: Kemmler, Georg, et al.
Publicado: (2019)

Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients
por: Kim, Seon Ha, et al.
Publicado: (2012)

Normative Data of the EORTC QLQ-C30 For the German Population: A Population-Based Survey
por: Waldmann, Annika, et al.
Publicado: (2013)

The EORTC QLQ-CR29 quality of life questionnaire for colorectal cancer: validation of the Dutch version
por: Stiggelbout, A. M., et al.
Publicado: (2015)

Assessment of Quality of Life of Chronic Myeloid Leukemia Patients by Using the EORTC QLQ-C30
por: Uğur, Mehmet Can, et al.
Publicado: (2017)

Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients
por: Dirven, Linda, et al.
Publicado: (2021)

Psychometric validation of the EORTC QLQ-HCC18 in patients with previously treated unresectable hepatocellular carcinoma
por: Serrano, Daniel, et al.
Publicado: (2021)

Cultural Adaptation and Validation of the Moroccan Version of the EORTC QLQ-CR29 in Patients with Colorectal Cancer
por: Yacir, El Alami, et al.
Publicado: (2022)

Mapping the EORTC QLQ-C30 and QLQ-H&N35 to the EQ-5D for head and neck cancer: Can disease-specific utilities be obtained?
por: Beck, Ann-Jean C. C., et al.
Publicado: (2019)

Data of real-world reference scores for EORTC QLQ-C30 and QLQ-BR23 at baseline in women with early breast cancer and other breast diseases
por: Gebert, Pimrapat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jcnjmrh2cv5oa8u0cdtejv0v5k